Nasenspray Sine (Xylometazoline Hydrochloride)

Xylometazoline Hydrochloride, the active ingredient in Nasenspray Sine, is an imidazoline nasal decongestant presented as a nasal spray for nasal use. It relieves nasal congestion associated with the common cold, sinusitis and allergic rhinitis in adults and children.

GNH USA supplies Nasenspray Sine as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Xylometazoline Hydrochloride is an imidazoline nasal decongestant that reduces swelling of the nasal mucosa.

- Common cold: alleviates nasal blockage by shrinking swollen nasal passages. - Sinusitis: diminishes mucosal edema to improve sinus drainage and relieve congestion. - Allergic rhinitis: reduces nasal obstruction caused by allergic inflammation.

Adverse reactions may occur with any nasal decongestant spray.

Common Side Effects: - Nasal irritation or burning sensation. - Dryness of the nasal mucosa. - Sneezing or mild headache. - Bitter taste after application.

Serious or Rare Side Effects: - Rebound congestion (rhinitis medicamentosa) after prolonged use. - Severe hypertension or arrhythmia. - Nasal ulceration or epistaxis. - Allergic reactions including rash, angioedema or anaphylaxis.

Use Nasenspray Sine according to professional guidance and observe the following precautions.

- Use duration: limit to 3‑5 days to avoid rebound congestion. - Age restrictions: not recommended for children under 2 years unless directed by a clinician. - Pregnancy: consult a healthcare professional before use. - Cardiovascular disease: employ with caution in patients with hypertension or heart disease. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Xylometazoline may interact with other sympathomimetic agents and certain cardiovascular drugs.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): may potentiate hypertensive effects. - Other nasal decongestants: risk of excessive vasoconstriction. - Sympathomimetic oral decongestants (e.g., pseudoephedrine): increased cardiovascular strain. - Beta‑blockers: may mask tachycardia caused by the spray.

Moderate Interactions (Monitor Closely): - Antihypertensive agents: possible reduction in blood‑pressure control. - Central nervous system stimulants: monitor for heightened blood pressure. - Alcohol: may enhance dizziness or light‑headedness.